pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
INM-901
Alzheimer's Disease
$INMInMed Pharmaceuticals Inc.
0 catalysts
Phase 2
INNA-051
Viral Respiratory Tract Infection
ENA Respiratory Pty Ltd
0 catalysts
Phase 1
INO-8000
Hepatitis C
$INOINOVIO PHARMACEUTICALS, INC.
0 catalysts
Phase 1
← prev
page 96 of 231
next →
131
Pain89
Neurology1
INS-1201
Duchenne Muscular Dystrophy
$INSMINSMED Inc
0 catalysts
Phase 1
INS-1202
Amyotrophic Lateral Sclerosis
$INSMINSMED Inc
0 catalysts
Phase 1
INT-301
Peanut Allergy
Intrommune Therapeutics Inc
0 catalysts
INTRALIPID
INTRALIPID (I. V. FAT EMULSION)
FRESENIUS
0 catalysts
INTROVALE
INTROVALE (LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS)
XIROMED
0 catalysts
Phase 1
INV-101
Ulcerative Colitis
Innovo Therapeutics Co Ltd
0 catalysts
Preclinical
INV-441
Glioblastoma Multiforme (GBM)
InvIOs GmbH
0 catalysts
Preclinical
INV-724
Neuroblastoma
Invenra Inc
0 catalysts
Phase 2
INV-9956
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ionova Life Science Co Ltd
0 catalysts
Phase 1
INVA-8001
Atopic Dermatitis (Atopic Eczema)
Invea Therapeutics Inc
0 catalysts
Phase 2
INX-315
Epithelial Ovarian Cancer
Incyclix Bio LLC
0 catalysts
Phase 1
IO-202
Chronic Myelomonocytic Leukemia (CMML)
Immune Onc Therapeutics Inc
0 catalysts
Preclinical
IO-312
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Immune Onc Therapeutics Inc
0 catalysts
IODIXANOL
IODIXANOL (IODIXANOL)
HENGRUI PHARMA
0 catalysts
IOFLUPANE I 123
IOFLUPANE I 123 (IOFLUPANE I-123)
CURIUM
0 catalysts
Phase 2
ION-283
Lafora Disease (Unverricht Disease)
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
Phase 2
ION-356
Pelizaeus-Merzbacher Disease (PMD)
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
IONOSOL MB AND DEXTROSE
IONOSOL MB AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE)
OTSUKA ICU MEDCL
0 catalysts
IOPAMIDOL
IOPAMIDOL (IOPAMIDOL)
HAINAN POLY
0 catalysts
Phase 2
IOV-2001
Chronic Lymphocytic Leukemia (CLL)
$IOVAIOVANCE BIOTHERAPEUTICS, INC.
0 catalysts
Phase 2
IOV-4001
Metastatic Melanoma
$IOVAIOVANCE BIOTHERAPEUTICS, INC.
0 catalysts
Phase 2
IPG-7236
Head And Neck Cancer
Immunophage Biotech Co Ltd
0 catalysts
Phase 1
IPH-4502
Breast Cancer
$IPHAInnate Pharma SA
0 catalysts
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)
CIPLA
0 catalysts
IPRATROPIUM BROMIDE INHALATION
IPRATROPIUM BROMIDE INHALATION (IPRATROPIUM BROMIDE INHALATION)
ARMSTRONG PHARMS
0 catalysts
Preclinical
IR-101C
Coronavirus Disease 2019 (COVID-19)
Immune Response BioPharma Inc
0 catalysts
IRINOTECAN HYDROCHLOIDE
IRINOTECAN HYDROCHLOIDE (IRINOTECAN HYDROCHLOIDE)
GLAND
0 catalysts